Session Details

Co-Chairs:

• Bernd Schröder, PhD,  Miltenyi Biotec B.V. & Co. KG,tGermany
• Carmen Sanges, PhD, Universitätsklinikum Würzburg, Germany

Speakers:

• Carole Moukheiber, PharmD, Servier, France - Focus on the viral safety of raw & starting materials for CAR-T cell products
• Bernd Schröder, PhD, Miltenyi Biotec B.V. & Co. KG, Germany - Regulatory requirements on raw material
• Nina Worel, MD, PhD, Medical University of Vienna, Austria - Influence of leukaphereses quality on CAR-T-Cell manufacturing

• Manel Juan, MD, PhD, Hospital Clinic Barcelona, Spain

This session will discuss the approach to selecting and handling raw and starting materials in CAR-T manufacturing. This will result in a more efficient process and ultimately safe and effective CAR-T cell products.

Session Objectives:

1. Specific aspects of raw material for CAR-T manufacturing
2. Key aspects to select the right raw material supplier
3. Lessons learned from CAR-T manufacturer